CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-26 | Paterson Dan President and CEO | Sale 10b5-1 | −2,000 | $10.32 | $21K | 430,818 |
| 2025-11-25 | Paterson Dan President and CEO | Sale 10b5-1 | −2,000 | $10.00 | $20K | 432,818 |
| 2025-11-24 | Paterson Dan President and CEO | Sale 10b5-1 | −2,000 | $10.00 | $20K | 434,818 |
| 2025-11-21 | Bunn Paul A. Director | Sale 10b5-1 | −6,250 | $10.00 | $63K | 2,083 |
| 2025-11-21 | Bunn Paul A. Director | Option exercise 10b5-1 | +6,250 | $3.27 | $20K | 8,333 |
| 2025-11-21 | Bunn Paul A. Director | Option exercise · Stock Options (right to buy) 10b5-1 | −6,250 | 6,250 | ||
| 2025-11-21 | Kauffman Michael Director | Sale 10b5-1 | −8,550 | $10.00 | $86K | 8,666 |
| 2025-11-21 | Paterson Dan President and CEO | Sale 10b5-1 | −2,000 | $10.00 | $20K | 436,818 |
| 2025-11-03 | Paterson Dan President and CEO | Sale 10b5-1 | −1,299 | $9.35 | $12K | 440,818 |
| 2025-11-03 | Paterson Dan President and CEO | Sale 10b5-1 | −2,000 | $10.00 | $20K | 438,818 |
| 2025-10-09 | Bunn Paul A. Director | Sale 10b5-1 | −8,333 | $9.06 | $75K | 8,333 |
| 2025-09-24 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −25 | $9.23 | $231 | 109,838 |
| 2025-09-22 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −57 | $9.08 | $518 | 109,863 |
| 2025-09-16 | Stuglik Brian M Director | Sale 10b5-1 | −587 | $9.99 | $6K | 101,739 |
| 2025-09-16 | Gagnon Robert E. Director | Sale 10b5-1 | −281 | $9.99 | $3K | 41,961 |
| 2025-09-16 | Paterson Dan President and CEO | Sale 10b5-1 | −390 | $9.99 | $4K | 442,117 |
| 2025-08-06 | Paterson Dan President and CEO | Sale 10b5-1 | −1,332 | $5.81 | $8K | 442,507 |
| 2025-06-23 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −25 | $4.71 | $118 | 109,920 |
| 2025-06-20 | Paterson Dan President and CEO | Sale 10b5-1 | −17,808 | $5.13 | $91K | 443,839 |
| 2025-06-20 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −4,110 | $5.13 | $21K | 109,945 |
Page 3 of 17 · 326 trades